![The Impact of Single Indication Orphan Drugs on the Future of Rare Diseases](https://static.wixstatic.com/media/e4f174_347bc47777994af5bf74c5f84ed91689~mv2.png/v1/fill/w_298,h_224,fp_0.50_0.50,q_95,enc_auto/e4f174_347bc47777994af5bf74c5f84ed91689~mv2.webp)
The Impact of Single Indication Orphan Drugs on the Future of Rare Diseases
According to a new study by FDA and HHS researchers published in the January 2024 issue of Health Affairs , 65% of 491 novel drugs (NMEs)...
What is the impact of rare diseases on individuals and health care systems?
A new NIH study on fourteen rare disease populations revealed the cost of rare disease healthcare to be three to five times higher than...
![Congressionally funded report details diagnostic challenges and costs of rare diseases in the US](https://static.wixstatic.com/media/e4f174_8a24285ff63b413d9321374670ef80de~mv2.png/v1/fill/w_298,h_214,fp_0.50_0.50,q_95,enc_auto/e4f174_8a24285ff63b413d9321374670ef80de~mv2.webp)
Congressionally funded report details diagnostic challenges and costs of rare diseases in the US
On October 18, 2021, the Government Accountability Office (GAO) published a report entitled, Rare Diseases: Although Limited, Available...
![Diagnostics: Moving to the forefront of Global Healthcare](https://static.wixstatic.com/media/e4f174_61c454b8109c435dbf0744439e87d5d8~mv2.png/v1/fill/w_298,h_224,fp_0.50_0.50,q_95,enc_auto/e4f174_61c454b8109c435dbf0744439e87d5d8~mv2.webp)
Diagnostics: Moving to the forefront of Global Healthcare
Diligentia Strategy is pleased to participate at the Southeast Life Sciences conference October 27-29 in Charleston, SC. Joff Masukawa...
![Economic Burden of Rare Diseases Nearly $1 Trillion](https://static.wixstatic.com/media/e4f174_0aa5b39923224ebc9a8567c0d08c89a3~mv2.png/v1/fill/w_298,h_224,fp_0.50_0.50,q_95,enc_auto/e4f174_0aa5b39923224ebc9a8567c0d08c89a3~mv2.webp)
Economic Burden of Rare Diseases Nearly $1 Trillion
While there are estimated to be more than 7,000 rare diseases, The National Economic Burden of Rare Disease Study includes 379 rare...
![CBO Comparison of Brand-Name Drug Prices Among Selected Federal Programs](https://static.wixstatic.com/media/e4f174_44e327e7f49647009fd9892dc5b6ed70~mv2.png/v1/fill/w_298,h_224,fp_0.50_0.50,q_95,enc_auto/e4f174_44e327e7f49647009fd9892dc5b6ed70~mv2.webp)
CBO Comparison of Brand-Name Drug Prices Among Selected Federal Programs
On February 18, 2021, the Congressional Budget Office (CBO) published a report entitled, A Comparison of Brand-Name Drug Prices Among...